NRC Health Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 9.14K shares, a 8.68% decline year-over-year.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 10.01K shares, a 86.70% decline year-over-year.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 75.28K shares, a 259.55% increase year-over-year.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-06-30 was 20.00K shares.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 22.36K shares, a 70.30% decline from fiscal 2024.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 75.28K shares, a 13.84% decline from fiscal 2023.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 87.38K shares, a 270.54% increase from fiscal 2022.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 23.58K shares, a 79.80% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-03-31 | 9.14K shares 10-Q · filed 2026-08-04 | |
| 2025-12-31 | 22.36K shares 10-K · filed 2026-03-05 | |
| 2025-03-31 | 10.01K shares 10-Q · filed 2026-08-04 | |
| 2024-12-31 | 75.28K shares 10-K · filed 2026-03-05 | |
| 2024-03-31 | 75.28K shares 10-Q · filed 2025-11-07 | |
| 2023-12-31 | 87.38K shares 10-K · filed 2026-03-05 | |
| 2023-06-30 | 20.00K shares 10-Q · filed 2024-11-08 | |
| 2023-03-31 | 20.94K shares 10-Q · filed 2024-11-08 | |
| 2022-12-31 | 23.58K shares 10-K · filed 2025-03-17 | |
| 2022-09-30 | 23.58K shares 10-Q · filed 2023-11-09 | |
| 2021-12-31 | 116.75K shares 10-K · filed 2024-02-27 | |
| 2021-09-30 | 10.00K shares 10-Q · filed 2022-11-04 | |
| 2021-03-31 | 68.28K shares 10-Q · filed 2022-11-04 | |
| 2020-12-31 | 630.37K shares 10-K · filed 2023-03-03 | |
| 2020-09-30 | 103.61K shares 10-Q · filed 2021-11-05 | 563.18K shares derived: sum of 4 quarters · filed 2022-03-04 |
| 2020-06-30 | 148.28K shares 10-Q · filed 2021-11-05 | 532.42K shares derived: sum of 4 quarters · filed 2022-03-04 |
| 2020-03-31 | 260.48K shares 10-Q · filed 2021-11-05 | 402.14K shares derived: sum of 4 quarters · filed 2022-03-04 |
| 2019-12-31 | 50.81K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | 227.90K shares 10-K · filed 2022-03-04 |
| 2019-09-30 | 72.84K shares 10-Q · filed 2020-11-06 | |
| 2019-06-30 | 18.00K shares 10-Q · filed 2020-11-06 | |
| 2019-03-31 | 86.25K shares 10-Q · filed 2020-11-06 | |
| 2013-03-31 | 39.75K shares 10-Q · filed 2013-05-08 | |
| 2012-12-31 | 426.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | 262.10K shares 10-K · filed 2013-03-01 |
| 2012-09-30 | -47.64K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |